Higher bleeding risk is tied to SSRIs, surgery study finds

05/21/2013

A study in JAMA Internal Medicine has found a link between the use of selective serotonin reuptake inhibitors, a common class of antidepressants, and a greater risk of surgery-related bleeding, transfusion, readmission and death. Scientists analyzed data on more than 530,000 operations at 375 hospitals. Researchers called for a prospective observational study on the effects of SSRIs in surgery.

View Full Article in:

Nurse.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA